Tourmaline Bio News

H.C. Wainwright Maintains Tourmaline Bio(TRML.US) With Buy Rating, Raises Target Price to $49

Futu NewsNov 12 01:31

Tourmaline Bio's Promising Clinical Developments and Financial Stability Underpin Buy Rating

TipRanksNov 11 14:34

Guggenheim Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsNov 5 02:31

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsNov 4 20:35

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 25 19:31

Piper Sandler Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $65

Futu NewsOct 17 19:31

Cantor Fitzgerald Initiates Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 15 21:33

Guggenheim Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 12 08:31

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 11 19:36

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsSep 11 19:31

Truist Financial Remains a Buy on Tourmaline Bio (TRML)

TipRanksSep 11 19:09

Piper Sandler Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $65

Futu NewsSep 4 19:33

Tourmaline Bio (TRML) Receives a Buy From Piper Sandler

TipRanksSep 4 18:59

Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)

TipRanksAug 13 23:17

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating, Announces Target Price $15

Futu NewsAug 13 21:31

Tourmaline Bio Analyst Ratings

BenzingaAug 12 19:32

HC Wainwright & Co. Reiterates Buy on Tourmaline Bio, Maintains $48 Price Target

BenzingaAug 12 19:32

Buy Rating Affirmed for Tourmaline Bio Amid Promising Clinical Trials and Strong Market Potential

TipRanksAug 12 18:25

Buy Rating Affirmed for Tourmaline Bio Amid Progress in TOUR006 Trials and Expansion Opportunities

TipRanksMay 16 16:15

Truist Financial Reaffirms Their Buy Rating on Tourmaline Bio (TRML)

TipRanksMay 14 22:10